Vaccines typically take years of research and testing before it reaches the masses, but scientists in Russia have reported that the Covid-19 vaccine is showing some positivity in early-stage trials.
Named “Sputnik-V,” The Lancet medical journal reported that after two trials involving 76 participants, 100% of participants developed antibodies to the new coronavirus without any severe side effects.
“The two 42-day trials – including 38 healthy adults each – did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response.”
“Large, long-term trials including a placebo comparison and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection.”
Russia licensed the two-shot jab vaccine for domestic use in August, despite not publishing any data or large scale trials.
The next step for the vaccine is that it will now enter a 40,000 strong later-stage trial.
Let’s hope that this major breakthrough in developing a vaccine to fight Covid-19 will eventually spur the need to bring the world back to what it was before the pandemic!
Also read: SG Researchers Discover Covid-19 Variant With Milder Infection, Good For Vaccine Development
